Shimazawa R, Takayama H, Fujimoto Y, Komoda M, Dodo K, Yamasaki R, Shirai R, Koiso Y, Miyata K, Kato F, Kato M, Miyachi H, Hashimoto Y
Institute of Molecular and Cellular Biosciences, University of Tokyo, Japan.
J Enzyme Inhib. 1999;14(4):259-75. doi: 10.3109/14756369909030321.
A novel series of small molecule nonpeptide aminopeptidase N (APN) inhibitors with a N-phenylphthalimide or N-phenylhomophthalimide skeleton were prepared. Evaluation of their protease inhibitory activities revealed that (i) some N-phenylphthalimide analogs are potent APN inhibitors, but they are also inhibitors of another protease, dipeptidylpeptidase IV (DPP-IV), and (ii) some N-phenylhomophthalimide analogs, including 2-(2,6-diethylphenyl)-1,2,3,4-tetrahydroisoquinoline-1,3-dione (PIQ-22), are potent and specific inhibitors of APN without DPP-IV-inhibitory activity. The structure-activity relationship studies of N-phenylphthalimides and N-phenylhomophthalimides are reviewed. PIQ-22 showed potent tumor-cell invasion-inhibitory activity.
制备了一系列具有N-苯基邻苯二甲酰亚胺或N-苯基高邻苯二甲酰亚胺骨架的新型小分子非肽氨肽酶N(APN)抑制剂。对其蛋白酶抑制活性的评估表明:(i)一些N-苯基邻苯二甲酰亚胺类似物是有效的APN抑制剂,但它们也是另一种蛋白酶二肽基肽酶IV(DPP-IV)的抑制剂;(ii)一些N-苯基高邻苯二甲酰亚胺类似物,包括2-(2,6-二乙基苯基)-1,2,3,4-四氢异喹啉-1,3-二酮(PIQ-22),是有效的APN特异性抑制剂,没有DPP-IV抑制活性。综述了N-苯基邻苯二甲酰亚胺和N-苯基高邻苯二甲酰亚胺的构效关系研究。PIQ-22显示出强大的肿瘤细胞侵袭抑制活性。